2282 related articles for article (PubMed ID: 9204888)
41. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
42. Characterization of C415 mutants of neuronal nitric oxide synthase.
Richards MK; Clague MJ; Marletta MA
Biochemistry; 1996 Jun; 35(24):7772-80. PubMed ID: 8672477
[TBL] [Abstract][Full Text] [Related]
43. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
Roma GW; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
45. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
46. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
Gonvindaraj S; Li H; Poulos TL
Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
[TBL] [Abstract][Full Text] [Related]
47. Aromatic substitution of the FAD-shielding tryptophan reveals its differential role in regulating electron flux in methionine synthase reductase and cytochrome P450 reductase.
Meints CE; Simtchouk S; Wolthers KR
FEBS J; 2013 Mar; 280(6):1460-74. PubMed ID: 23332101
[TBL] [Abstract][Full Text] [Related]
48. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI.
Lawson RJ; von Wachenfeldt C; Haq I; Perkins J; Munro AW
Biochemistry; 2004 Oct; 43(39):12390-409. PubMed ID: 15449930
[TBL] [Abstract][Full Text] [Related]
49. Importance of the domain-domain interface to the catalytic action of the NO synthase reductase domain.
Welland A; Garnaud PE; Kitamura M; Miles CS; Daff S
Biochemistry; 2008 Sep; 47(37):9771-80. PubMed ID: 18717591
[TBL] [Abstract][Full Text] [Related]
50. P450BM-3: reduction by NADPH and sodium dithionite.
Peterson JA; Boddupalli SS
Arch Biochem Biophys; 1992 May; 294(2):654-61. PubMed ID: 1567220
[TBL] [Abstract][Full Text] [Related]
51. An appraisal of multiple NADPH binding-site models proposed for cytochrome P450 reductase, NO synthase, and related diflavin reductase systems.
Daff S
Biochemistry; 2004 Apr; 43(13):3929-32. PubMed ID: 15049700
[TBL] [Abstract][Full Text] [Related]
52. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR
Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785
[TBL] [Abstract][Full Text] [Related]
53. A tryptophan that modulates tetrahydrobiopterin-dependent electron transfer in nitric oxide synthase regulates enzyme catalysis by additional mechanisms.
Wang ZQ; Wei CC; Santolini J; Panda K; Wang Q; Stuehr DJ
Biochemistry; 2005 Mar; 44(12):4676-90. PubMed ID: 15779894
[TBL] [Abstract][Full Text] [Related]
54. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
[TBL] [Abstract][Full Text] [Related]
55. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
[TBL] [Abstract][Full Text] [Related]
56. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
Davis CA; Dhawan IK; Johnson MK; Barber MJ
Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
[TBL] [Abstract][Full Text] [Related]
57. The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase.
Neeli R; Girvan HM; Lawrence A; Warren MJ; Leys D; Scrutton NS; Munro AW
FEBS Lett; 2005 Oct; 579(25):5582-8. PubMed ID: 16214136
[TBL] [Abstract][Full Text] [Related]
58. Electron transfer is activated by calmodulin in the flavin domain of human neuronal nitric oxide synthase.
Guan ZW; Iyanagi T
Arch Biochem Biophys; 2003 Apr; 412(1):65-76. PubMed ID: 12646269
[TBL] [Abstract][Full Text] [Related]
59. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
Loughran PA; Roman LJ; Miller RT; Masters BS
Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
[TBL] [Abstract][Full Text] [Related]
60. Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1.
Faulkner KM; Shet MS; Fisher CW; Estabrook RW
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7705-9. PubMed ID: 7644480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
